| Identification | |
| Name: | Aliskiren hemifumarate |
| Synonyms: | Aliskiren fumarate;Bis(2S,4S,5S,7S)-5-amino-N-(3-amino-2,2-dimethyl-3-oxopropyl)-4-hydroxy-7-(4-methoxy-3-(3-methoxypropoxy)benzyl)-8-methyl-2-(1-methylethyl)nonanamide) (2E)-but-2-enedioate; |
| CAS: | 173334-58-2 |
| Molecular Formula: | 2(C30H53N3O6).C4H4O4 |
| Molecular Weight: | 1219.60 |
| InChI: | InChI=1/2C30H53N3O6.C4H4O4/c2*1-19(2)22(14-21-10-11-26(38-8)27(15-21)39-13-9-12-37-7)16-24(31)25(34)17-23(20(3)4)28(35)33-18-30(5,6)29(32)36;5-3(6)1-2-4(7)8/h2*10-11,15,19-20,22-25,34H,9,12-14,16-18,31H2,1-8H3,(H2,32,36)(H,33,35);1-2H,(H,5,6)(H,7,8)/b;;2-1+/t2*22-,23-,24-,25-;/m00./s1 |
| Molecular Structure: |  |
| Properties | |
| Appearance: | white powder |
| Usage: | An orally active, synthetic nonpeptide renin inhibitor. Antihypertensive. |
| Safety Data | |
 |
|
